Industries > Pharma > mRNA Vaccines Market Report 2021-2031
mRNA Vaccines Market Report 2021-2031
Forecasts by Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, Immune System, Other Treatment Type), by Type mRNA Vaccines (Non-Replicating mRNA, In-Vivo Self-Replicating mRNA, In-Vitro Non-Replicating mRNA, Other mRNA Type), by Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement, Other), by End-user (Hospitals and Clinics, Research Organizations, Other End-user), by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines, Other Vaccine Types). Plus Analysis of Leading Regional and National Markets and Analysis of Leading mRNA Companies
mRNA vaccines are key in this COVID-19 pandemic situation?
Vaccines are crucial now. The race for a COVID-19 vaccine is not just a race for profit or market share, but a race to save increased death, and rescue the global economy. The ability to mimic the natural viral infection and therefore produce the antigen proteins from within the cell is seen by many as the best form of protection from this novel coronavirus.
But this isn’t the only mRNA vaccine being developed. Other key vaccines areas such as cancer, respiratory illness, and HIV etc. are essential opportunities within mRNA vaccine development.
You need to discover how this will impact the market today, and over the next 10 years:
• Our in-depth, dedicated 460+-page report contains more than 650 tables and diagrams.
• Delivers best-benefit areas for short- to long-term mRNA vaccine and future prospects
• Analyses, for you, global, regional and national sales
• Highlights successful results, trends, changes and revenue projections
• Tells you how to profit best from mRNA vaccines today.
This report tells you:
• How key players in the mRNA market are strategically increasing/ decreasing/ holding their positions?
• What are the funding trends in the mRNA vaccines market?
• Development scenarios and global confidence regarding mRNA vaccines
• Technological and structural changes occurring in the vaccine industry and how they effect you
• Growth assessments within the mRNA vaccines industry during the forecast timeline?
This report is not available to everyone. Just a few of these reports exist. Make sure you get your copy immediately.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
The emergence of a mRNA Vaccine
The mRNA vaccine market is constantly thriving to improve vaccine efficiency and provide better protection each season. Is this possible? Pharma companies tackle novel approaches to vaccine technology, better administration and delivery, plus production of the vaccine. Never has this been more critical – yet never before has it offered you such opportunity for development.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares of your main competitors.
• Original analyses – this is not available anywhere else
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Product Pipeline Analysis, product profiles and commercial developments.
UNIQUE COVID-19 VARIATIONS – only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 effects the economy.
Discover sales predictions for the world market and submarkets
By Treatment Type
• Bioengineered Vaccine
• Gene Therapy
• Gene Transcription
• Cell Therapy
• Monoclonal Antibody
• Immune System
• Other Treatment Type
By Type mRNA Vaccines
• Non-replicating mRNA
• In-vivo Self-replicating mRNA
• In-vitro Non-replicating mRNA
• Other mRNA Type
By Application
• Cancer
• Infectious Disease
• Gene Editing
• Protein Replacement
• Other
By End-User
• Hospitals and Clinics
• Research Organizations
• Other End-User
By Vaccine Type
• Self-amplifying mRNA-based Vaccines
• Conventional Non-Amplifying mRNA-Based Vaccines
• Other Vaccine Types
The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential. These technologies are the instruments required for the marketing of mRNA vaccines to achieve higher efficacy in people.
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
By Region
• North America:
• U.S.
• Canada
• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia Pacific:
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia Pacific
• Latin America:
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa:
• Turkey
• Saudi Arabia
• Iran
• South Africa
• UAE
• Rest of Middle East & Africa
Need industry data? Please contact us today.
How the mRNA Vaccines Market report helps you?
In summary, our 460+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for mRNA Vaccines Market, forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 14 key national markets – See forecasts for the mRNA Vaccines market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the mRNA Vaccines Market.
• AstraZeneca PLC
• Bausch Health Companies Inc.,
• Bayer Inc.
• Eli Lilly and Company
• Roche Holding AG (Roche)
• Genentech, Inc.
• Merck & Co., Inc.
• Metropolis Healthcare Limited
• Moderna, Inc.
• Mymetics Corporation
• Ligand Pharmaceuticals Incorporated (Ligand)
• Pfizer Inc. (Pfizer)
• Sanofi
• Vertex Pharmaceuticals Incorporated
• Virbac Pharmaceutical
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the mRNA Vaccines Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today mRNA Vaccines Market Report 2021-2031: Forecasts by Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, Immune System, Other Treatment Type), by Type mRNA Vaccines (Non-Replicating mRNA, In-Vivo Self-Replicating mRNA, In-Vitro Non-Replicating mRNA, Other mRNA Type), by Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement, Other), by End-user (Hospitals and Clinics, Research Organizations, Other End-user), by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines, Other Vaccine Types). Plus Analysis of Leading Regional and National Markets and Analysis of Leading mRNA Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Study Goals and Objectives
1.2 Scope of the Report
1.3 Target Audience
1.4 Why You Should Buy This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report Include:
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.9 Market Evaluation & Forecasting Methodology
1.10 COIVD-19 Impact Recovery Pattern Analysis
1.10.1 V-Shaped Recovery
1.10.2 U-Shaped Recovery
1.10.3 W-Shaped Recovery
1.10.4 L-Shaped Recovery
1.11 Frequently Asked Questions (FAQ)
1.12 Associated Visiongain Reports
1.13 About Visiongain
2. Executive Summary
2.1 Segment Insights
2.2 COVID-19 Impact on mRNA Vaccines Market
3. mRNA Vaccines Overview
3.1 Conception And Forms Of mRNA Vaccines
3.2 Engineered mRNA With Potent Efficiency
3.3 Advantages and Disadvantages
3.4 mRNA Vaccines in The Prevention Of Infectious Disease
3.5 Delivery Route and Formulation Of mRNA Vaccines
3.6 Mechanism of Immune Response Induced by mRNA Vaccines
4. mRNA Vaccines Pipeline
4.1 Advantages and Disadvantages of mRNA Vaccines (and comparison to DNA vaccines).
4.1.1 Advantages:
4.1.2 Disadvantages:
5. COVID-19 Vaccine Research & Development Overview
5.1 DRAFT landscape of COVID-19 candidate vaccines – 20 April 2020
6. Market Dynamics
6.1 How Important Are Vaccines?
6.2 Is mRNA Vaccination in Demand?
6.3 What about Rise of Antibiotic Resistance?
6.4 What is the Current Market Situation?
6.5 What it Takes to Develop and Launch New Vaccines?
6.6 How Increased R&D Efforts Are Impacting mRNA Vaccines
6.7 Why there is Increased Demand from Emerging Markets?
6.8 How High Pricing of mRNA Vaccines Affecting Growth Rate?
6.9 How Government Initiatives are Helpful for mRNA Vaccines Sales?
6.10 How Improving Access to Sustainable Immunization Services will Help?
6.11 Which Economic Factors Influence Vaccine Sales
6.12 How Vaccine Supply is Restraints Market Growth?
6.13 What are the Funding Trends in Global Market?
6.14 How Technological Advancements such as Rapid Manufacturing and Others are Impacting Vaccines Market?
6.15 Is High Cost Associated with mRNA Vaccine Dose to Limit Adoption?
7. Global mRNA Vaccine Market Estimation & Forecast
7.1 COVID Impact Recovery Analysis (V, W, U, L Shape)
7.2 by Region: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.3 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.4 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.5 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.6 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.7 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8. North America mRNA Vaccine Market Estimation & Forecast
8.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.3 US Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.3.1 US Will Always Have A Secured Access to Abundant Supply Of The Various Vaccines Available On The Market
8.4 Canada Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.4.1 Canada Focuses to Increase Awareness Regarding the Value of Vaccines
8.5 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.6 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.7 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.8 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.9 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9. Europe mRNA Vaccine Market Estimation & Forecast
9.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.3 Russia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.3.1 Russian Vaccines Market Is Due To See Modest Revenue Growth
9.4 Germany Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.4.1 Germany is One of the Leaders in Vaccine Research & Development
9.5 UK Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.5.1 The U.K. is one of the major contributors to the vaccine market.
9.6 France Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.6.1 France Is One Of The Major Countries To Produce Vaccines
9.7 Italy Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.7.1 Economic Situation In Italy Will Be A Real Restricting Factor For Vaccine R&D
9.8 Rest of Europe Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10. Asia-Pacific mRNA Vaccine Market Estimation & Forecast
10.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.3 China Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.3.1 China Is Expected To See Tremendous Growth Within The Human Vaccines Market
10.4 Japan Market : COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.4.1 Amount of Investment for mRNA Vaccine R&D is on the Rise
10.5 India Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.5.1 Indian Vaccines Market Holds Great Potential Due To Its Sheer Population
10.6 South Korea Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.6.1 Korean Companies Are Stepping Up Efforts To Advance Into The Global Health Market With Korean Vaccines.
10.7 Australia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.7.1 Vaccine Manufacturers Are Continuously Harnessing Their Scientific Knowledge and Technologies to Design Safe and Effective Vaccines
10.8 Rest of Asia-Pacific: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11. Middle East & Africa mRNA Vaccine Market Estimation & Forecast
11.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.3 Turkey Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.3.1 Governments Will Be More Inclined to Sponsor the Funding of Vaccines
11.4 Saudi Arabia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.4.1 Saudi Arabia's Healthcare Landscape Will Continue To Evolve As The Government Pursues Reforms
11.5 South Africa Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.5.1 Vaccination Coverage Is Low Because Governments Struggle To Deliver Vaccines To The Most Remote Areas
11.6 Iran Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.6.1 The Vaccine Industry Is One of the Most Important Health-Related Industries
11.7 UAE Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.7.1 UAE in Competition to Develop Vaccines for COVID-19
11.8 Rest of MEA Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.8.1 Middle East and Africa are laggards when it comes to immunization coverage.
11.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12. Latin America mRNA Vaccine Market Estimation & Forecast
12.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.3 Brazil Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.3.1 The Brazilian Human Vaccines Market Is the Largest in South America
12.4 Mexico Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.4.1 Strong Tendency To Increase The Participation Of The Private Sector in Vaccine R&D
12.5 Rest of LA Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.6 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.7 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.8 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.9 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.10 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
13. Company Profiles
13.1 AstraZeneca Pharmaceutical Company
13.1.1 Business Overview
13.1.2 Company Financial Profile
13.1.3 Product and Service Offerings
13.1.4 Recent Developments
13.2 Bausch Health Companies Inc.
13.2.1 Business Overview
13.2.2 Company Financial Profile
13.2.3 Product and Service Offerings
13.2.4 Recent Developments
13.3 Bayer Inc.
13.3.1 Business Overview
13.3.2 Company Financial Profile
13.3.3 Product and Service Offerings
13.3.4 Recent Developments
13.4 Eli Lilly and Company
13.4.1 Business Overview
13.4.2 Company Financial Profile
13.4.3 Product and Service Offerings
13.4.4 Recent Developments
13.5 F. Hoffmann-La Roche AG.
13.5.1 Business Overview
13.5.2 Company Financial Profile
13.5.3 Product and Service Offerings
13.5.4 Recent Developments
13.6 Genentech Biotechnology Company
13.6.1 Business Overview
13.6.2 Company Financial Profile
13.6.3 Product and Service Offerings
13.6.4 Recent Developments
13.7 Merck & Co. Pharmaceutical Company
13.7.1 Business Overview
13.7.2 Company Financial Profile
13.7.3 Product and Service Offerings
13.7.4 Recent Developments
13.8 Metropolis Healthcare Ltd Clinical Laboratory Company
13.8.1 Business Overview
13.8.2 Company Financial Profile
13.8.3 Product and Service Offerings
13.8.4 Recent Developments
13.9 Moderna Biotechnology Company.
13.9.1 Business Overview
13.9.2 Company Financial Profile
13.9.3 Product and Service Offerings
13.9.4 Recent Developments
13.10 Mymetics Corporation Company.
13.10.1 Business Overview
13.10.2 Company Financial Profile
13.10.3 Product and Service Offerings
13.10.4 Recent Developments
13.11 Open Monoclonal Technology, Inc. (Ligand Pharmaceuticals)
13.11.1 Business Overview
13.11.2 Company Financial Profile
13.11.3 Product and Service Offerings
13.11.4 Recent Developments
13.12 Pfizer Pharmaceutical Company.
13.12.1 Business Overview
13.12.2 Company Financial Profile
13.12.3 Product and Service Offerings
13.12.4 Recent Developments
13.13 Sanofi Pasteur Pharmaceutical Company.
13.13.1 Business Overview
13.13.2 Company Financial Profile
13.13.3 Product and Service Offerings
13.13.4 Recent Developments
13.14 Vertex Biopharmaceutical Company.
13.14.1 Business Overview
13.14.2 Company Financial Profile
13.14.3 Product and Service Offerings
13.14.4 Recent Developments
13.15 Virbac Pharmaceutical Company.
13.15.1 Business Overview
13.15.2 Company Financial Profile
13.15.3 Product and Service Offerings
13.15.4 Recent Developments
14. Conclusion and Recommendations
14.1 Other Key Player in the Global Market
14.2 List of Organizations Related to mRNA Market
15. Glossary
List of Figure
Figure 3.1 Overview of mRNA Vaccines Mechanism
Figure 7.1 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.2 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.3 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.4 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.5 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.6 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.7 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.8 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.9 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.10 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.11 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.12 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.13 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.14 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.15 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.16 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.17 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.18 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.19 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.20 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.21 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.22 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.23 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.24 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.25 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.26 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.27 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.28 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.29 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.30 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.31 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.32 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.33 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.34 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.35 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.1 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.2 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.3 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.4 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.5 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.6 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.7 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.8 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.9 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.10 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.11 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.12 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.13 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.14 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.15 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.16 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.17 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.18 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.19 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.20 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.21 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.22 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.23 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.24 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.25 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.26 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.27 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.28 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.29 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.30 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.31 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.32 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.33 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.34 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.35 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.1 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.2 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.3 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.4 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.5 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.6 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.7 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.8 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.9 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.10 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.11 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.12 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.13 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.14 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.15 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.16 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.17 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.18 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.19 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.20 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.21 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.22 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.23 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.24 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.25 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.26 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.27 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.28 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.29 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.30 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.31 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.32 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.33 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.34 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.35 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.1 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.2 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.3 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.4 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.5 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.6 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.7 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.8 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.9 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.10 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.11 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.12 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.13 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.14 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.15 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.16 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.17 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.18 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.19 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.20 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.21 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.22 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.23 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.24 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.25 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.26 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.27 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.28 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.29 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.30 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.31 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.32 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.33 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.34 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.1 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.2 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.3 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.4 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.5 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.6 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.7 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.8 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.9 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.10 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.11 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.12 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.13 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.14 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.15 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.16 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.17 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.18 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.19 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.20 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.21 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.22 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.23 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.24 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.25 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.26 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.27 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.28 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.29 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.30 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.31 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.32 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.33 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.34 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.35 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.1 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.2 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.3 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.4 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.5 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.6 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.7 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.8 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.9 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.10 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.11 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.12 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.13 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.14 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.15 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.16 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.17 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.18 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.19 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.20 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.21 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.22 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.23 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.24 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.25 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.26 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.27 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.28 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.29 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.30 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.31 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.32 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.33 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.34 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.35 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 13.1 AstraZeneca Pharmaceutical Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.2 AstraZeneca Pharmaceutical Company: Company Operating Income 2015-2019 (US$Mn)
Figure 13.3 AstraZeneca Pharmaceutical Company: Company EBITDA 2015-2019 (US$Mn)
Figure 13.4 AstraZeneca Pharmaceutical Company: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.5 Bausch Health Companies Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.6 Bausch Health Companies Inc.: Company Operating Income 2015-2019 (US$Mn)
Figure 13.7 Bausch Health Companies Inc.: Company EBITDA 2015-2019 (US$Mn)
Figure 13.8 Bausch Health Companies Inc.: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.9 Bayer Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.10 Bayer Inc.: Company Operating Income 2015-2019 (US$Mn)
Figure 13.11 Bayer Inc.: Company EBITDA 2015-2019 (US$Mn)
Figure 13.12 Bayer Inc.: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.13 Eli Lilly and Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.14 Eli Lilly and Company: Company Operating Income 2015-2019 (US$Mn)
Figure 13.15 Eli Lilly and Company: Company EBITDA 2015-2019 (US$Mn)
Figure 13.16 Eli Lilly and Company: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.17 F. Hoffmann-La Roche AG: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.18 F. Hoffmann-La Roche AG: Company Operating Income 2015-2019 (US$Mn)
Figure 13.19 F. Hoffmann-La Roche AG: Company EBITDA 2015-2019 (US$Mn)
Figure 13.20 F. Hoffmann-La Roche AG: Company Net Income/Loss 2015-2019 (US$Mn)
List of Tables
Table 2.1 Global mRNA Vaccines Market Summary Table
Table 3.1 Advantages and Disadvantages of Viral Vectored Vaccines, DNA vaccines and RNA vaccines.
Table 3.2 Nucleoside modified or non-modified mRNA vaccines against infectious diseases.
Table 3.3 Self-amplifying mRNA vaccines against infectious diseases.
Table 4.1 AstraZeneca.: Company mRNA Vaccines Pipeline
Table 4.2 Bausch Health Pharmaceutical.: Company mRNA Vaccines Pipeline
Table 4.3 Lilly.: Company mRNA Vaccines Pipeline
Table 4.4 Roche.: Company mRNA Vaccines Pipeline
Table 4.5 Merck & Co.: Company mRNA Vaccines Pipeline
Table 4.6 Astrazeneca.: Company mRNA Vaccines Pipeline
Table 4.7 Astrazeneca.: Company mRNA Vaccines Pipeline
Table 4.8 Sanofi Pasteur S.A.: Company mRNA Vaccines Pipeline
Table 4.9 Bayer Inc.: Company mRNA Vaccines Pipeline
Table 4.10 Mymetics Corporation Company mRNA Vaccines Pipeline
Table 4.11 Genentech, Inc: Company mRNA Vaccines Pipeline
Table 4.12 Vertex Pharmaceuticals.: Company mRNA Vaccines Pipeline
Table 5.1 5 Candidate Vaccines In Clinical Evaluation
Table 5.2 71 candidate vaccines in preclinical evaluation
Table 6.1 mRNA Vaccine Industry Growth Driving Forces
Table 7.1 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.2 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.3 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.4 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.5 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.6 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.7 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.8 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.9 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.10 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.11 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.12 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.13 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.14 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.15 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.16 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.17 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.18 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.19 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.20 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.21 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.22 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.23 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.24 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.25 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.26 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.27 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.28 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.29 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.30 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.31 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.32 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.33 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.34 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.35 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.1 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.2 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.3 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.4 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.5 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.6 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.7 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.8 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.9 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.10 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.11 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.12 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.13 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.14 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.15 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.16 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.17 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.18 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.19 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.20 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.21 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.22 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.23 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.24 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.25 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.26 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.27 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.28 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.29 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.30 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.31 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.32 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.33 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.34 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.35 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.36 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.37 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.38 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.39 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.40 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.1 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.2 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.3 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.4 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.5 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.6 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.7 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.8 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.9 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.10 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.11 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.12 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.13 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.14 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.15 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.16 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.17 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.18 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.19 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.20 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.21 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.22 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.23 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.24 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.25 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.26 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.27 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.28 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.29 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.30 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.31 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.32 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.33 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.34 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.35 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.36 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.37 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.38 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.39 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.40 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.41 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.42 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.43 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.44 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.45 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.46 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.47 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.48 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.49 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.50 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.51 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.52 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.53 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.54 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.55 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.56 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.57 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.58 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.59 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.60 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.1 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.2 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.3 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.4 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.5 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.6 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.7 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.8 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.9 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.10 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.11 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.12 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.13 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.14 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.15 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.16 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.17 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.18 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.19 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.20 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.21 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.22 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.23 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.24 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.25 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.26 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.27 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.28 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.29 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.30 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.31 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.32 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.33 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.34 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.35 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.36 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.37 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.38 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.39 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.40 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.41 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.42 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.43 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.44 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.45 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.46 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.47 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.48 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.49 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.50 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.51 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.52 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.53 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.54 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.55 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.56 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.57 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.58 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.59 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.1 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.2 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.3 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.4 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.5 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.6 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.7 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.8 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.9 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.10 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.11 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.12 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.13 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.14 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.15 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.16 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.17 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.18 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.19 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.20 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.21 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.22 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.23 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.24 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.25 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.26 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.27 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.28 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.29 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.30 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.31 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.32 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.33 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.34 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.35 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.36 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.37 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.38 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.39 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.40 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.41 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.42 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.43 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.44 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.45 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.46 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.47 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.48 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.49 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.50 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.51 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.52 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.53 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.54 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.55 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.56 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.57 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.58 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.59 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.60 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.1 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.2 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.3 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.4 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.5 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.6 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.7 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.8 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.9 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.10 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.11 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.12 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.13 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.14 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.15 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.21 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.22 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.23 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.24 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.25 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.26 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.27 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.28 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.29 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.30 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.31 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.32 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.33 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.34 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.35 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.36 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.37 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.38 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.39 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.40 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.41 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.42 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.43 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.44 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.45 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.46 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.47 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.48 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.49 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.50 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.1 AstraZeneca Pharmaceutical Company: Company Information
Table 13.2AstraZeneca Pharmaceutical Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.3AstraZeneca Pharmaceutical Company: Company Product and Service Offerings
Table 13.4AstraZeneca Pharmaceutical Company: Company Recent Developments till July,2020
Table 13.5 Bausch Health Companies Inc. Company Information
Table 13.6Bausch Health Companies Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.7Bausch Health Companies Inc.: Company Product and Service Offerings
Table 13.8Bausch Health Companies Inc.: Company Recent Developments till July,2020
Table 13.9 Bayer Inc. Company Information
Table 13.10Bayer Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.11 Bayer Inc.: Company Product and Service Offerings
Table 13.12Bayer Inc.: Company Recent Developments till July,2020
Table 13.13 Eli Lilly and Company: Company Information
Table 13.14 Eli Lilly and Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.15Eli Lilly and Company: Company Product and Service Offerings
Table 13.16Eli Lilly and Company: Company Recent Developments till July,2020
Table 13.17F. Hoffmann-La Roche AG Company Information
Table 13.18F. Hoffmann-La Roche AG: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.19F. Hoffmann-La Roche AG: Company Product and Service Offerings
Table 13.20F. Hoffmann-La Roche AG: Company Recent Developments till July,2020
Table 13.21 Genentech, Inc. Company Information
Table 13.22Genentech, Inc.: Company Product and Service Offerings
Table 13.23Genentech, Inc.: Company Recent Developments till July,2020
1.1 Study Goals and Objectives
1.2 Scope of the Report
1.3 Target Audience
1.4 Why You Should Buy This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report Include:
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.9 Market Evaluation & Forecasting Methodology
1.10 COIVD-19 Impact Recovery Pattern Analysis
1.10.1 V-Shaped Recovery
1.10.2 U-Shaped Recovery
1.10.3 W-Shaped Recovery
1.10.4 L-Shaped Recovery
1.11 Frequently Asked Questions (FAQ)
1.12 Associated Visiongain Reports
1.13 About Visiongain
2. Executive Summary
2.1 Segment Insights
2.2 COVID-19 Impact on mRNA Vaccines Market
3. mRNA Vaccines Overview
3.1 Conception And Forms Of mRNA Vaccines
3.2 Engineered mRNA With Potent Efficiency
3.3 Advantages and Disadvantages
3.4 mRNA Vaccines in The Prevention Of Infectious Disease
3.5 Delivery Route and Formulation Of mRNA Vaccines
3.6 Mechanism of Immune Response Induced by mRNA Vaccines
4. mRNA Vaccines Pipeline
4.1 Advantages and Disadvantages of mRNA Vaccines (and comparison to DNA vaccines).
4.1.1 Advantages:
4.1.2 Disadvantages:
5. COVID-19 Vaccine Research & Development Overview
5.1 DRAFT landscape of COVID-19 candidate vaccines – 20 April 2020
6. Market Dynamics
6.1 How Important Are Vaccines?
6.2 Is mRNA Vaccination in Demand?
6.3 What about Rise of Antibiotic Resistance?
6.4 What is the Current Market Situation?
6.5 What it Takes to Develop and Launch New Vaccines?
6.6 How Increased R&D Efforts Are Impacting mRNA Vaccines
6.7 Why there is Increased Demand from Emerging Markets?
6.8 How High Pricing of mRNA Vaccines Affecting Growth Rate?
6.9 How Government Initiatives are Helpful for mRNA Vaccines Sales?
6.10 How Improving Access to Sustainable Immunization Services will Help?
6.11 Which Economic Factors Influence Vaccine Sales
6.12 How Vaccine Supply is Restraints Market Growth?
6.13 What are the Funding Trends in Global Market?
6.14 How Technological Advancements such as Rapid Manufacturing and Others are Impacting Vaccines Market?
6.15 Is High Cost Associated with mRNA Vaccine Dose to Limit Adoption?
7. Global mRNA Vaccine Market Estimation & Forecast
7.1 COVID Impact Recovery Analysis (V, W, U, L Shape)
7.2 by Region: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.3 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.4 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.5 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.6 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
7.7 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8. North America mRNA Vaccine Market Estimation & Forecast
8.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.3 US Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.3.1 US Will Always Have A Secured Access to Abundant Supply Of The Various Vaccines Available On The Market
8.4 Canada Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.4.1 Canada Focuses to Increase Awareness Regarding the Value of Vaccines
8.5 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.6 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.7 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.8 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
8.9 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9. Europe mRNA Vaccine Market Estimation & Forecast
9.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.3 Russia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.3.1 Russian Vaccines Market Is Due To See Modest Revenue Growth
9.4 Germany Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.4.1 Germany is One of the Leaders in Vaccine Research & Development
9.5 UK Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.5.1 The U.K. is one of the major contributors to the vaccine market.
9.6 France Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.6.1 France Is One Of The Major Countries To Produce Vaccines
9.7 Italy Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.7.1 Economic Situation In Italy Will Be A Real Restricting Factor For Vaccine R&D
9.8 Rest of Europe Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
9.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10. Asia-Pacific mRNA Vaccine Market Estimation & Forecast
10.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.3 China Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.3.1 China Is Expected To See Tremendous Growth Within The Human Vaccines Market
10.4 Japan Market : COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.4.1 Amount of Investment for mRNA Vaccine R&D is on the Rise
10.5 India Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.5.1 Indian Vaccines Market Holds Great Potential Due To Its Sheer Population
10.6 South Korea Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.6.1 Korean Companies Are Stepping Up Efforts To Advance Into The Global Health Market With Korean Vaccines.
10.7 Australia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.7.1 Vaccine Manufacturers Are Continuously Harnessing Their Scientific Knowledge and Technologies to Design Safe and Effective Vaccines
10.8 Rest of Asia-Pacific: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
10.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11. Middle East & Africa mRNA Vaccine Market Estimation & Forecast
11.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.3 Turkey Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.3.1 Governments Will Be More Inclined to Sponsor the Funding of Vaccines
11.4 Saudi Arabia Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.4.1 Saudi Arabia's Healthcare Landscape Will Continue To Evolve As The Government Pursues Reforms
11.5 South Africa Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.5.1 Vaccination Coverage Is Low Because Governments Struggle To Deliver Vaccines To The Most Remote Areas
11.6 Iran Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.6.1 The Vaccine Industry Is One of the Most Important Health-Related Industries
11.7 UAE Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.7.1 UAE in Competition to Develop Vaccines for COVID-19
11.8 Rest of MEA Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.8.1 Middle East and Africa are laggards when it comes to immunization coverage.
11.9 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.10 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.11 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.12 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
11.13 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12. Latin America mRNA Vaccine Market Estimation & Forecast
12.1 by Value: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.2 by Country: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.3 Brazil Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.3.1 The Brazilian Human Vaccines Market Is the Largest in South America
12.4 Mexico Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.4.1 Strong Tendency To Increase The Participation Of The Private Sector in Vaccine R&D
12.5 Rest of LA Market: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.6 by Treatment Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.7 by mRNA Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.8 by Application: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.9 by End-User: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
12.10 by Vaccine Type: COVID Impact Recovery Analysis (V, W, U, L- Shaped)
13. Company Profiles
13.1 AstraZeneca Pharmaceutical Company
13.1.1 Business Overview
13.1.2 Company Financial Profile
13.1.3 Product and Service Offerings
13.1.4 Recent Developments
13.2 Bausch Health Companies Inc.
13.2.1 Business Overview
13.2.2 Company Financial Profile
13.2.3 Product and Service Offerings
13.2.4 Recent Developments
13.3 Bayer Inc.
13.3.1 Business Overview
13.3.2 Company Financial Profile
13.3.3 Product and Service Offerings
13.3.4 Recent Developments
13.4 Eli Lilly and Company
13.4.1 Business Overview
13.4.2 Company Financial Profile
13.4.3 Product and Service Offerings
13.4.4 Recent Developments
13.5 F. Hoffmann-La Roche AG.
13.5.1 Business Overview
13.5.2 Company Financial Profile
13.5.3 Product and Service Offerings
13.5.4 Recent Developments
13.6 Genentech Biotechnology Company
13.6.1 Business Overview
13.6.2 Company Financial Profile
13.6.3 Product and Service Offerings
13.6.4 Recent Developments
13.7 Merck & Co. Pharmaceutical Company
13.7.1 Business Overview
13.7.2 Company Financial Profile
13.7.3 Product and Service Offerings
13.7.4 Recent Developments
13.8 Metropolis Healthcare Ltd Clinical Laboratory Company
13.8.1 Business Overview
13.8.2 Company Financial Profile
13.8.3 Product and Service Offerings
13.8.4 Recent Developments
13.9 Moderna Biotechnology Company.
13.9.1 Business Overview
13.9.2 Company Financial Profile
13.9.3 Product and Service Offerings
13.9.4 Recent Developments
13.10 Mymetics Corporation Company.
13.10.1 Business Overview
13.10.2 Company Financial Profile
13.10.3 Product and Service Offerings
13.10.4 Recent Developments
13.11 Open Monoclonal Technology, Inc. (Ligand Pharmaceuticals)
13.11.1 Business Overview
13.11.2 Company Financial Profile
13.11.3 Product and Service Offerings
13.11.4 Recent Developments
13.12 Pfizer Pharmaceutical Company.
13.12.1 Business Overview
13.12.2 Company Financial Profile
13.12.3 Product and Service Offerings
13.12.4 Recent Developments
13.13 Sanofi Pasteur Pharmaceutical Company.
13.13.1 Business Overview
13.13.2 Company Financial Profile
13.13.3 Product and Service Offerings
13.13.4 Recent Developments
13.14 Vertex Biopharmaceutical Company.
13.14.1 Business Overview
13.14.2 Company Financial Profile
13.14.3 Product and Service Offerings
13.14.4 Recent Developments
13.15 Virbac Pharmaceutical Company.
13.15.1 Business Overview
13.15.2 Company Financial Profile
13.15.3 Product and Service Offerings
13.15.4 Recent Developments
14. Conclusion and Recommendations
14.1 Other Key Player in the Global Market
14.2 List of Organizations Related to mRNA Market
15. Glossary
List of Figure
Figure 3.1 Overview of mRNA Vaccines Mechanism
Figure 7.1 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.2 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.3 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.4 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.5 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.6 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.7 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.8 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.9 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.10 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.11 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.12 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.13 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.14 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.15 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.16 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.17 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.18 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.19 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.20 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.21 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.22 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.23 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.24 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.25 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.26 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.27 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.28 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.29 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.30 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 7.31 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 7.32 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 7.33 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 7.34 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 7.35 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.1 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.2 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.3 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.4 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.5 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.6 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.7 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.8 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.9 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.10 North America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.11 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.12 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.13 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.14 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.15 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.16 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.17 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.18 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.19 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.20 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.21 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.22 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.23 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.24 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.25 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.26 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.27 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.28 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.29 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.30 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 8.31 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 8.32 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 8.33 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 8.34 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 8.35 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.1 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.2 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.3 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.4 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.5 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.6 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.7 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.8 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.9 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.10 Europe mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.11 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.12 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.13 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.14 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.15 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.16 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.17 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.18 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.19 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.20 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.21 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.22 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.23 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.24 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.25 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.26 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.27 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.28 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.29 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.30 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 9.31 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 9.32 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 9.33 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 9.34 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 9.35 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.1 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.2 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.3 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.4 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.5 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.6 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.7 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.8 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.9 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.10 Asia-Pacific mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.11 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.12 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.13 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.14 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.15 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.16 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.17 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.18 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.19 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.20 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.21 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.22 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.23 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.24 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.25 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.26 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.27 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.28 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.29 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 10.30 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 10.31 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 10.32 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 10.33 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 10.34 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.1 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.2 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.3 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.4 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.5 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.6 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.7 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.8 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.9 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.10 Middle East & Africa mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.11 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.12 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.13 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.14 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.15 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.16 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.17 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.18 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.19 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.20 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.21 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.22 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.23 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.24 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.25 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.26 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.27 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.28 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.29 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.30 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 11.31 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 11.32 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 11.33 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 11.34 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 11.35 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.1 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.2 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.3 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.4 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.5 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.6 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.7 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.8 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.9 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.10 Latin America mRNA Vaccines Market by Country Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.11 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.12 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.13 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.14 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.15 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.16 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.17 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.18 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.19 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.20 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.21 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.22 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.23 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.24 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.25 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.26 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.27 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.28 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.29 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.30 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 12.31 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %)
Figure 12.32 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (V-Shaped Recovery)
Figure 12.33 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (W-Shaped Recovery)
Figure 12.34 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (U-Shaped Recovery)
Figure 12.35 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %) (L-Shaped Recovery)
Figure 13.1 AstraZeneca Pharmaceutical Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.2 AstraZeneca Pharmaceutical Company: Company Operating Income 2015-2019 (US$Mn)
Figure 13.3 AstraZeneca Pharmaceutical Company: Company EBITDA 2015-2019 (US$Mn)
Figure 13.4 AstraZeneca Pharmaceutical Company: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.5 Bausch Health Companies Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.6 Bausch Health Companies Inc.: Company Operating Income 2015-2019 (US$Mn)
Figure 13.7 Bausch Health Companies Inc.: Company EBITDA 2015-2019 (US$Mn)
Figure 13.8 Bausch Health Companies Inc.: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.9 Bayer Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.10 Bayer Inc.: Company Operating Income 2015-2019 (US$Mn)
Figure 13.11 Bayer Inc.: Company EBITDA 2015-2019 (US$Mn)
Figure 13.12 Bayer Inc.: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.13 Eli Lilly and Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.14 Eli Lilly and Company: Company Operating Income 2015-2019 (US$Mn)
Figure 13.15 Eli Lilly and Company: Company EBITDA 2015-2019 (US$Mn)
Figure 13.16 Eli Lilly and Company: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 13.17 F. Hoffmann-La Roche AG: Company Revenue 2015-2019 (US$ Mn, AGR %)
Figure 13.18 F. Hoffmann-La Roche AG: Company Operating Income 2015-2019 (US$Mn)
Figure 13.19 F. Hoffmann-La Roche AG: Company EBITDA 2015-2019 (US$Mn)
Figure 13.20 F. Hoffmann-La Roche AG: Company Net Income/Loss 2015-2019 (US$Mn)
List of Tables
Table 2.1 Global mRNA Vaccines Market Summary Table
Table 3.1 Advantages and Disadvantages of Viral Vectored Vaccines, DNA vaccines and RNA vaccines.
Table 3.2 Nucleoside modified or non-modified mRNA vaccines against infectious diseases.
Table 3.3 Self-amplifying mRNA vaccines against infectious diseases.
Table 4.1 AstraZeneca.: Company mRNA Vaccines Pipeline
Table 4.2 Bausch Health Pharmaceutical.: Company mRNA Vaccines Pipeline
Table 4.3 Lilly.: Company mRNA Vaccines Pipeline
Table 4.4 Roche.: Company mRNA Vaccines Pipeline
Table 4.5 Merck & Co.: Company mRNA Vaccines Pipeline
Table 4.6 Astrazeneca.: Company mRNA Vaccines Pipeline
Table 4.7 Astrazeneca.: Company mRNA Vaccines Pipeline
Table 4.8 Sanofi Pasteur S.A.: Company mRNA Vaccines Pipeline
Table 4.9 Bayer Inc.: Company mRNA Vaccines Pipeline
Table 4.10 Mymetics Corporation Company mRNA Vaccines Pipeline
Table 4.11 Genentech, Inc: Company mRNA Vaccines Pipeline
Table 4.12 Vertex Pharmaceuticals.: Company mRNA Vaccines Pipeline
Table 5.1 5 Candidate Vaccines In Clinical Evaluation
Table 5.2 71 candidate vaccines in preclinical evaluation
Table 6.1 mRNA Vaccine Industry Growth Driving Forces
Table 7.1 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.2 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.3 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.4 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.5 Global mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.6 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.7 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.8 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.9 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.10 Global mRNA Vaccines Market by Region Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.11 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.12 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.13 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.14 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.15 Global mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.16 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.17 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.18 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.19 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.20 Global mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.21 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.22 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.23 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.24 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.25 Global mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.26 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.27 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.28 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.29 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.30 Global mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.31 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 7.32 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.33 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.34 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.35 Global mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.1 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.2 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.3 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.4 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.5 North America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.6 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.7 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.8 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.9 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.10 US mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.11 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.12 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.13 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.14 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.15 Canada mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.16 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.17 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.18 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.19 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.20 North America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.21 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.22 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.23 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.24 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.25 North America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.26 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.27 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.28 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.29 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.30 North America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.31 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.32 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.33 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.34 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.35 North America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.36 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 8.37 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.38 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.39 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.40 North America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.1 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.2 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.3 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.4 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.5 Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.6 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.7 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.8 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.9 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.10 Russia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.11 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.12 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.13 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.14 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.15 Germany mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.16 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.17 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.18 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.19 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.20 UK mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.21 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.22 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.23 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.24 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.25 France mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.26 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.27 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.28 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.29 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.30 Italy mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.31 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.32 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.33 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.34 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.35 Rest of Europe mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.36 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.37 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.38 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.39 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.40 Europe mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.41 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.42 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.43 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.44 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.45 Europe mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.46 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.47 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.48 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.49 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.50 Europe mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.51 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.52 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.53 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.54 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.55 Europe mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.56 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 9.57 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.58 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.59 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.60 Europe mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.1 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.2 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.3 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.4 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.5 Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.6 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.7 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.8 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.9 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.10 China mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.11 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.12 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.13 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.14 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.15 Japan mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.16 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.17 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.18 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.19 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.20 India mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.21 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.22 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.23 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.24 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.25 South Korea mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.26 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.27 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.28 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.29 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.30 Australia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.31 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.32 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.33 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.34 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.35 Rest of Asia-Pacific mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.36 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.37 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.38 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.39 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.40 Asia-Pacific mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.41 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.42 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.43 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.44 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.45 Asia-Pacific mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.46 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.47 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.48 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.49 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.50 Asia-Pacific mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.51 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.52 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.53 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.54 Asia-Pacific mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.55 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 10.56 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.57 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.58 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.59 Asia-Pacific mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.1 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.2 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.3 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.4 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.5 Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.6 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.7 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.8 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.9 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.10 Turkey mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.11 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.12 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.13 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.14 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.15 Saudi Arabia mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.16 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.17 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.18 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.19 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.20 South Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.21 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.22 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.23 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.24 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.25 Iran mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.26 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.27 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.28 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.29 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.30 UAE mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.31 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.32 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.33 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.34 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.35 Rest of Middle East & Africa mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.36 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.37 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.38 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.39 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.40 Middle East & Africa mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.41 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.42 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.43 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.44 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.45 Middle East & Africa mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.46 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.47 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.48 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.49 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.50 Middle East & Africa mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.51 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.52 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.53 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.54 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.55 Middle East & Africa mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.56 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 11.57 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.58 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.59 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.60 Middle East & Africa mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.1 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.2 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.3 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.4 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.5 Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.6 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.7 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.8 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.9 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.10 Brazil mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.11 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.12 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.13 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.14 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.15 Mexico mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.21 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.22 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.23 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.24 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.25 Rest of Latin America mRNA Vaccines Market by Value Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.26 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.27 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.28 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.29 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.30 Latin America mRNA Vaccines Market by Treatment Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.31 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.32 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.33 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.34 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.35 Latin America mRNA Vaccines Market by mRNA Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.36 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.37 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.38 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.39 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.40 Latin America mRNA Vaccines Market by Application Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.41 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.42 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.43 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.44 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.45 Latin America mRNA Vaccines Market by End-User Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.46 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %)
Table 12.47 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.48 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.49 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.50 Latin America mRNA Vaccines Market by Vaccine Type Forecast 2021-2031 (US$ Billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.1 AstraZeneca Pharmaceutical Company: Company Information
Table 13.2AstraZeneca Pharmaceutical Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.3AstraZeneca Pharmaceutical Company: Company Product and Service Offerings
Table 13.4AstraZeneca Pharmaceutical Company: Company Recent Developments till July,2020
Table 13.5 Bausch Health Companies Inc. Company Information
Table 13.6Bausch Health Companies Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.7Bausch Health Companies Inc.: Company Product and Service Offerings
Table 13.8Bausch Health Companies Inc.: Company Recent Developments till July,2020
Table 13.9 Bayer Inc. Company Information
Table 13.10Bayer Inc.: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.11 Bayer Inc.: Company Product and Service Offerings
Table 13.12Bayer Inc.: Company Recent Developments till July,2020
Table 13.13 Eli Lilly and Company: Company Information
Table 13.14 Eli Lilly and Company: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.15Eli Lilly and Company: Company Product and Service Offerings
Table 13.16Eli Lilly and Company: Company Recent Developments till July,2020
Table 13.17F. Hoffmann-La Roche AG Company Information
Table 13.18F. Hoffmann-La Roche AG: Company Revenue 2015-2019 (US$ Mn, AGR %)
Table 13.19F. Hoffmann-La Roche AG: Company Product and Service Offerings
Table 13.20F. Hoffmann-La Roche AG: Company Recent Developments till July,2020
Table 13.21 Genentech, Inc. Company Information
Table 13.22Genentech, Inc.: Company Product and Service Offerings
Table 13.23Genentech, Inc.: Company Recent Developments till July,2020
List of Companies Profiled
AstraZeneca PLC
Bausch Health Companies Inc.,
Bayer Inc.
Eli Lilly and Company
Genentech, Inc.
Ligand Pharmaceuticals Incorporated (Ligand)
Merck & Co., Inc.
Metropolis Healthcare Limited
Moderna, Inc.
Mymetics Corporation
Pfizer Inc. (Pfizer)
Roche Holding AG (Roche)
Sanofi
Vertex Pharmaceuticals Incorporated
Virbac Pharmaceutical
List of Other Companies Mentioned in the Report
Adaptive Biotechnologies Corporation
Arcturus Therapeutics Ltd.
Argos Therapeutics, Inc.
BioNTech AG
Bioverativ Inc.
Brammer Bio
Caperna LLC
CELLSCRIPT, LLC
CureVac AG
Dow AgroSciences LLC
Effimune
Elpidera LLC
eTheRNA immunotherapies NV
ethris GmbH
Genevant Sciences
In-Cell-Art
Institut Pasteur
Kite Pharma, Inc.
MAB Discovery GmbH
Mymetics BV
Okinawa Health Biotechnology Research and Development Center
PCI Biotech
Personalis, Inc.
Pharmaceutical Product Development, LLC (PPD)
Sangamo Therapeutics, Inc.
Shire International GmbH
Shuwen Biotech Co. Ltd.
Sigma-Aldrich Corporation
Tiba Biotech LLC
Translate Bio, Inc.
TxCell, SA
Valeant Pharmaceuticals International Inc.
Valera LLC
List of Organizations Mentioned in the Report
American Cancer Society (ACS)
American Diabetes Organization (ADO)
Bill & Melinda Gates Foundation
Biomedical Advanced Research and Development Authority (BARDA)
Cancer Research UK
Defense Advanced Research Projects Agency
Friedrich-Loeffler-Institute
Institute of Immunology of the Centre de Recherche Public-Santé (CRP)
Karolinska Institutet
Karolinska University Hospital (KUH)
The Coalition for Epidemic Preparedness Innovations (CEPI)
U.S. Food and Drug Administration (FDA)
University of Pennsylvania (Penn)
World Health Organization (WHO)
AstraZeneca PLC
Bausch Health Companies Inc.,
Bayer Inc.
Eli Lilly and Company
Genentech, Inc.
Ligand Pharmaceuticals Incorporated (Ligand)
Merck & Co., Inc.
Metropolis Healthcare Limited
Moderna, Inc.
Mymetics Corporation
Pfizer Inc. (Pfizer)
Roche Holding AG (Roche)
Sanofi
Vertex Pharmaceuticals Incorporated
Virbac Pharmaceutical
List of Other Companies Mentioned in the Report
Adaptive Biotechnologies Corporation
Arcturus Therapeutics Ltd.
Argos Therapeutics, Inc.
BioNTech AG
Bioverativ Inc.
Brammer Bio
Caperna LLC
CELLSCRIPT, LLC
CureVac AG
Dow AgroSciences LLC
Effimune
Elpidera LLC
eTheRNA immunotherapies NV
ethris GmbH
Genevant Sciences
In-Cell-Art
Institut Pasteur
Kite Pharma, Inc.
MAB Discovery GmbH
Mymetics BV
Okinawa Health Biotechnology Research and Development Center
PCI Biotech
Personalis, Inc.
Pharmaceutical Product Development, LLC (PPD)
Sangamo Therapeutics, Inc.
Shire International GmbH
Shuwen Biotech Co. Ltd.
Sigma-Aldrich Corporation
Tiba Biotech LLC
Translate Bio, Inc.
TxCell, SA
Valeant Pharmaceuticals International Inc.
Valera LLC
List of Organizations Mentioned in the Report
American Cancer Society (ACS)
American Diabetes Organization (ADO)
Bill & Melinda Gates Foundation
Biomedical Advanced Research and Development Authority (BARDA)
Cancer Research UK
Defense Advanced Research Projects Agency
Friedrich-Loeffler-Institute
Institute of Immunology of the Centre de Recherche Public-Santé (CRP)
Karolinska Institutet
Karolinska University Hospital (KUH)
The Coalition for Epidemic Preparedness Innovations (CEPI)
U.S. Food and Drug Administration (FDA)
University of Pennsylvania (Penn)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for mRNA Vaccines Market Report 2021-2031Related reports
Biopharmaceuticals Contract Manufacturing Market Report 2020-2030
As of 2019, the global biopharmaceuticals market’s size was estimated at ~$232 billion. It is expected to grow at a...
Full DetailsPublished: 04 March 2020Global Norovirus Vaccines in Pipeline Forecast 2020-2030
The global norovirus vaccines market is estimated to grow at a CAGR of 7.6% during the forecast period. In 2022,...Full DetailsPublished: 19 December 2019Healthcare Cold Chain Logistics Market Report 2020-2030
How will the global healthcare cold chain logistics industry evolve during this unique time? Visiongain’s report tells you 4 unique...
Full DetailsPublished: 09 September 2020Vaccines Sales Market Report 2020-2030
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New...
Full DetailsPublished: 10 September 2020Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030
Overall world revenue for CMO of sterile injectable drugs will surpass US$55.33 billion by 2030, our work calculates. We predict...
Full DetailsPublished: 01 May 2020Asia Vaccines Market Forecast to 2029
Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a CAGR of 8.8% during...
Full DetailsPublished: 28 October 2019Novel Coronavirus (COVID-19) Drugs in Development Market Forecast 2020-2030
Our 180+ page report provides 100+ tables, charts, and graphs. Read on to discover the most key areas in the...
Full DetailsPublished: 18 May 2020Top 25 Vaccines Market Forecast to 2029
Visiongain expects market growth from $25.19bn in 2018 to $40.80bn in 2024, growing at a CAGR of 8.42%. The developing...
Full DetailsPublished: 27 February 2020Global Live Vaccines Market Forecast 2020-2030
The global live vaccines market was valued at $10,423.4 mn in 2019 and is anticipated to surpass $ 20,020 mn...
Full DetailsPublished: 12 March 2020Vaccine Contract Manufacturing Market Forecast 2020-2030
The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of...
Full DetailsPublished: 08 April 2020
Download sample pages
Complete the form below to download your free sample pages for mRNA Vaccines Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain pharma reports catalogue?
What are the dynamic growth sectors? where are the regional business opportunities?
Which technologies will prevail and who are the leading companies succeeding in these sectors and why?
If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.
If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Biobanking Market Report 2021-2031
In clinical trials relating to COVID-19, COVID-19 biobanks will play an important role. These biobanks will play an instrumental role in future scientific studies on the emerging coronavirus (COVID-19) pandemic facing the world.
23 October 2020
Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030
Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.
19 October 2020
Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030
The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.
12 October 2020
Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030
We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
02 October 2020
